@article {Challenger2021.05.01.21256182, author = {Joseph D. Challenger and Cher Y. Foo and Yue Wu and Mahdi Moradi Marjaneh and Felicity Liew and Ryan S. Thwaites and Lucy C. Okell and Aubrey J. Cunnington}, title = {Modelling upper respiratory viral load dynamics of SARS-CoV-2}, elocation-id = {2021.05.01.21256182}, year = {2021}, doi = {10.1101/2021.05.01.21256182}, publisher = {Cold Spring Harbor Laboratory Press}, abstract = {The relationships between viral load, severity of illness, and transmissibility of virus, have been the subject of intense interest since the start of the COVID-19 pandemic. They are fundamental to understanding pathogenesis and devising better therapeutic and prevention strategies. In this report we present within-host modelling to examine the viral load dynamics observed in the upper respiratory tract, drawing upon 2172 serial measurements from 605 subjects, collected from 17 different studies. We developed a mechanistic within-host model to describe viral load dynamics and host response, and also contrasted simpler mixed-effects regression analysis of peak viral load and its subsequent decline. The inclusion of age, sex, or disease severity of the subjects did not appreciably improve the fit of either the mechanistic model or the regression. In future work, this model will be used to connect viral load dynamics to underlying host traits, to better understand these complex interactions.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by a research grant (MR/V027409/1) from UKRI (MRC) and DHSC (NIHR). Infrastructure support was provided by the NIHR Imperial Biomedical Research Centre. JDC and LCO acknowledge funding from the MRC Centre for Global Infectious Disease Analysis (reference MR/R015600/1), jointly funded by the UK Medical Research Council (MRC) and the UK Foreign, Commonwealth \& Development Office (FCDO), under the MRC/FCDO Concordat agreement and is also part of the EDCTP2 programme supported by the European Union.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethics statement: This study conducted secondary analysis of data from published studies. All studies included were either (i) approved by an institutional ethics review committee and obtained informed consent from all participants; or (ii) were exempted from this requirement because they involved identification, control, or prevention of disease in response to an immediate public health threat, and had been determined not to be public health research. Further ethical approval was not required for the present study which used only anonymised non-identifiable information from these studies.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAt present, we refer the reader back to the original studies (summarised in Table 1) to access or request the viral load data.}, URL = {https://www.medrxiv.org/content/early/2021/05/06/2021.05.01.21256182}, eprint = {https://www.medrxiv.org/content/early/2021/05/06/2021.05.01.21256182.full.pdf}, journal = {medRxiv} }